Home » Topics » Gastrointestinal, BioWorld Science

Gastrointestinal, BioWorld Science
RSS

Major active component of TJ-135 determined using hepatic stellate cells

Nov. 12, 2002

Data supporting ongoing clinical development of ACH-126443 for HBV presented at meetings

Nov. 12, 2002

Beneficial effects for NCX-1000 in animal model of cholangitis

Nov. 12, 2002

New mu/delta opioid receptor agonist under study for the management of GI motility disorders

Nov. 12, 2002

Potential use of nuclease-stabilized ribozymes in chronic HCV infection

Nov. 11, 2002

Mechanism of anti-HBV activity of AT-130 described at AASLD meeting

Nov. 11, 2002

FXR agonist has beneficial effects in rat model of hepatic injury

Nov. 11, 2002

Elan returns rights to HCV antisense drug to Isis

Nov. 8, 2002

Ribapharm submits IND for Hepavir B

Nov. 8, 2002

Pain Therapeutics to initiate pilot program for low-dose opioid antagonist therapy in IBS

Nov. 7, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...
mRNA flu vaccine can activate broad germinal center response
BioWorld
On the eve of the June 17 Vaccines and Related Biological Products Advisory Committee (VRBPAC) meeting, which will discuss Moderna Inc.’s mRNA-1010, researchers...
GLP-1s need technologies for long-term use
BioWorld
For the long-term impact of GLP-1 therapies in obesity to be realized, they must be paired with data and digital tools. While the drugs are effective, challenges...